Women treated for CIN3 at Greater Risk for Cervical Cancer

Holy Hormones Journal: Well Jan. 14 was sure good news for women day. First the article about breast cancer cells being sneaking around in the brain – and now we are finding out that women who were previously treated for cervical and vaginal cancer are at higher risk for getting the cancers again. Well, duh.

photo credit creative commons license AJC1

photo credit creative commons license AJC1

First of all, there are many who believe that biopsy’s cause cancerous cells to spread.  Think about it – sticking a needle into a breast or taking a swab or a cone on the cervix or vagina does not mean that the cancer is localized. Cells move, are displaced find their ways to other parts of the body right?  What would you do if your safe space was invaded – move to another safe place right?

Then there is the whole theory that cancerous cells have fungus… well fungus will be easily displaced and land on other cells right?

But the real misleading piece here is how cancer and medical treatments are views.  We rape, pillage, scrape, biopsy, amputate, mutilate, – but nowhere in the medical journals is a mention of NUTRATING (well maybe a few paragraphs) – to keep the body healthy and in homeostasis so that it can heal itself.

If you ask me.. or even if you did not, it appears someone is paving the way for another marketing push for the HPV vaccines, Gardasil and Cervarix.

Bottom line is if a woman has these types of cancers – or any cancer and she continues the same lifestyle of course they will return.

There are so many stories and studies coming out about the role of nutrition in healing the body -even from stage 4 cancer.

This is the era of new medicine folks… actually it is ancient women’s healing knowledge making a comeback… because what is out there is not working. Only makes money for the elitists.  And leaves most of the rest of us maimed and hopeless

Cervical, Vaginal Cancer Higher in Women Previously Treated for Pre-Cancerous Cells On Cervix, Study Finds

ScienceDaily
January 14, 2014

Women previously treated for abnormal cells on the cervix (CIN3 or cervical intraepithelial neoplasia grade 3) are at an increased risk of developing and dying from cervical or vaginal cancer compared with the general female population and this risk accelerates above age 60, a paper published today suggests.

Cytology screening to prevent cervical cancer is a medical success story and examinations have proven to be an effective way to reduce deaths from cervical cancer. However, the risk of cervical cancer is not eliminated when abnormal cells are detected and removed and as such women are asked to participate in follow-up programs.

No prior study has investigated how aging affects the risk of death from cervical cancer after treatment of CIN3. Researchers from Sahlgrenska University Hospital and Karolinska Institute in Sweden therefore aimed to investigate how age affected this risk.

They used data from the Swedish Cancer Registry which contained information on 150,883 women with CIN3, 1,089 of which had a diagnosis of invasive cervical cancer and 147 women who had a diagnosis of vaginal cancer. 302 and 53, respectively, had died of these diseases.

The researchers found there was an increased risk of invasive cervical and invasive vaginal cancer as women once treated for CIN3 grew older. The risk, compared to the general female population, accelerated after the age of 60. After the age of 75, incidence rates increased further with rates exceeding 100 per 100,000 women over this age. Also, the more recently a woman had been treated, the higher the risk of cancer.

Read full article…

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.